Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal luminal water and stool matrix represent the complex physiological environment within the gastrointestinal tract where the final stages of digestion and waste formation occur. Rather than being a single molecular target like a protein or receptor, this matrix is a heterogeneous mixture of water, electrolytes, undigested dietary components, and the gut microbiota (PubMed: PMID 30214149). It plays a critical role in maintaining osmotic balance and facilitating the transit of waste products through the colon. Therapeutic agents targeting this compartment, such as osmotic laxatives and stool softeners, work by altering the physical properties of the matrix—increasing water retention or decreasing surface tension—to alleviate constipation (StatPearls: Laxatives). Additionally, the stool matrix can be a site for sequestering toxins or bile acids through the use of adsorbents or resins, thereby preventing their systemic absorption (PubMed: PMID 25533146). The composition of the matrix is dynamic, influenced by diet, hydration status, and the metabolic activity of the microbiome. Changes in the volume or consistency of the luminal water can lead to clinical symptoms such as diarrhea or constipation, making it a key focus for gastrointestinal health management.
Drugs interact with this matrix through osmotic retention of water, reduction of surface tension to allow water penetration, increasing fecal bulk, or the adsorption of toxins and bile acids within the luminal space (StatPearls: Laxatives; PubMed: PMID 28945071).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal luminal water and stool matrix.